Skip to main content
. Author manuscript; available in PMC: 2019 Mar 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2018 Mar 1;77(3):295–298. doi: 10.1097/QAI.0000000000001596

Table 1.

N(%) or Mean(SD) Younger (N=23) Older (N=22) P-value

Age (yrs) 31 (3) 64 (4)

Sex
Female 2 (9%) 2 (9%) 1.0
Male 21 (91%) 20 (91%)

Race
African-American 2 (9%) 4 (18%) 0.4
Non African-American 21 (91%) 18 (82%)

Current smoker 12 (52%) 6 (27%) 0.1

Current HCV infection 0 (0%) 2 (9%) 0.2

TDF duration (yrs)
1 year 2 (9%) v 0.5
>1 year 21 (91%) 22 (100%)

Booster (RTV or COBI) 10 (43%) 10 (45%) >0.99
Creatinine Clearance (ml/min)
Cockroft Gault
119 (36) 96 (32) 0.03
Hematocrit (%) 44 (2.9) 44 (3.1) 0.7